Back to company

AMPLEXA GENETICS A/S: Financial statements 2012

CVR: 29428441

AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -538,092 and a net result of DKK -2,070,084. Equity amounted to DKK -6,961,218.

Gross Profit
-538,092 kr.
Profit/Loss
-2,070,084 kr.
Equity
-6,961,218 kr.
Total Assets
5,411,912 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is AMPLEXA GENETICS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About AMPLEXA GENETICS A/S

AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.